1,674
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Expectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbia

, , , , , , & show all
Pages 19-25 | Received 18 Sep 2016, Accepted 27 Sep 2017, Published online: 22 Nov 2017

References

  • Geurts MM, Zuydgeest IA, Walser S, et al. The evaluation of patient self-completion concordance forms used in community pharmacy: a comparison of two European countries. Int J Pharm Pract. 2014;22:186–192.
  • Geurts MM, Pot JL, Schepers EH, et al. The evaluation of an intervention based on the application of patient self-completion concordance forms in Dutch community pharmacies and the effect on adherence to chronic medication. Patient Educ Couns. 2010;78:85–90.
  • Lenander C, Elfsson B, Danielsson B, et al. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care. 2014;32:180–186.
  • Clifford S, Barber N, Elliot R, et al. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006;28:165–170.
  • Barnett CW, Nykamp D, Ellington AM. Patient-guided counseling in the community pharmacy setting. J Am Pharm Assoc (Wash). 2000;40:765–772.
  • Ryan R, Santesso N, Lowe D, et al. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. 2014;4:CD007768.
  • Horne R, Chapman S, Parham R, et al. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8:e80633.
  • Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728–740.
  • Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. Br Med J. 2008;336:1114–1117.
  • Sabaté E. Adherence to long-term therapies: evidence for action. World Health Organization (WHO); 2003. [cited 2017 October 3]. Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992
  • Tarn DM, Paterniti DA, Williams BR, et al. Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives. J Am Geriatr Soc. 2009;57:462–469.
  • Barber N, Parsons J, Clifford S, et al. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13:172–175.
  • Britten N, Stevenson FA, Barry CA, et al. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000;320:484–488.
  • Kessels R. Patients’ memory for medical information. J R Soc Med. 2003;96:219–222.
  • Lawrence J. Report finds new medicine service improves treatment adherence and saves NHS money. Pharm J. 2014;293:7824–7825.
  • Elliott RA, Barber N, Clifford S, et al. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm World Sci. 2008;30:17–23.
  • Kelly M, McCarthy S, Sahm L. Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature. Eur J Clin Pharmacol. 2014;70:1423–1431.
  • Elliott RA, Boyd MJ, Waring J, et al. Understanding and appraising the new medicines service in the NHS in England. 2016 [cited 2016 June 14] Available from: http://www.nottingham.ac.uk/∼pazmjb/nms/downloads/report/files/assets/basic-html/index.html#1
  • Kijlstra N, Ridge K, Walser S, Pharmaceutical care: where do we stand: where should we go? Survey report. Strasbourg, European Directorate for the Quality of Medicines & Healthcare (EDQM); 2009. Available from: https://www.edqm.eu/en/pharmaceutical-care-1517.html
  • Healthcare CoEEDftQoM. Quality indicators for pharmaceutical care: outcomes of the EDQM project and next steps. 2016. [cited 2016 July 17]. Available from: https://www.edqm.eu/sites/default/files/pc_quality_indicators_report.pdf
  • Specialist academic studies programs at Faculty of Pharmacy—University of Belgrade. 2016. [cited 2016 July 17]. Available from: http://www.pharmacy.bg.ac.rs/en/studies/146/specialist-academic-studies/
  • Horvat N, Kos M. Contribution of Slovenian community pharmacist counseling to patients’ knowledge about their prescription medicines: a cross-sectional study. Croat Med J. 2015;56:41–49.
  • Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. J Am Med Assoc. 2002;288:2880–2883.
  • Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
  • O’Carroll R, Chambers J, Dennis M, et al. Improving medication adherence in stroke survivors: mediators and moderators of treatment effects. Health Psychol. 2014;33:1241–1250.
  • Briesacher B, Andrade S, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28:437–443.
  • Reynolds K, Muntner P, Cheetham T, et al. Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporos Int. 2013;24:2509–2517.
  • Boswell K, Cook C, Burch S, et al. Associating medication adherence with improved outcomes: a systematic literature review. Am J Pharm Benefits. 2012;4:e97–108.